CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
91 hedge funds and large institutions have $1.36B invested in China Biologic Products Holdings, Inc. in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
7% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 30
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
91
Holding in Top 10
6
Calls
$21.1M
Puts
$2.42M
Top Buyers
| 1 | +$50.7M | |
| 2 | +$38M | |
| 3 | +$26.3M | |
| 4 |
Temasek Holdings
Singapore
|
+$25.5M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$24.2M |
Top Sellers
| 1 | -$13.7M | |
| 2 | -$13.1M | |
| 3 | -$12.3M | |
| 4 |
MAM
Myriad Asset Management
North Point,
Hong Kong
|
-$12.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.4M |